Research graph
References from Short-course vunakizumab associated with rapid improvement of acute flares in paediatric generalised pustular psoriasis: a three-patient case series. Local targets link to admitted publications; unresolved targets remain external evidence.
An update on generalized pustular psoriasis
10.1080/1744666x.2019.1648209 · 2019 · External reference
The update of treatment strategies in pediatrics with generalized pustular psoriasis in China
10.1002/ped4.12395 · 2023 · External reference
IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis
10.1016/j.jaci.2016.08.056 · 2017 · External reference
The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab
10.3389/fimmu.2023.1292941 · 2023 · External reference
Psoriasis pathogenesis and the development of novel targeted immune therapies
10.1016/j.jaci.2017.07.004 · 2017 · External reference
IL-36 and IL-17A cooperatively induce a psoriasis-like gene expression response in human keratinocytes
10.1016/j.jid.2021.01.019 · 2021 · External reference
Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, placebo-controlled phase 3 trial
10.1016/j.jaad.2024.09.031 · 2025 · External reference
Efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis across different regions of China: a post-hoc exploratory analysis of a phase III randomized controlled trial
10.1080/09546634.2025.2560505 · 2025 · External reference
Vunakizumab and acitretin for elderly refractory generalized pustular psoriasis: a case report and comprehensive literature review
10.2147/btt.s592069 · 2026 · External reference
Clinical disease measures in generalized pustular psoriasis
10.1007/s40257-021-00653-0 · 2022 · External reference
Successful treatment of paediatric generalized pustular psoriasis with secukinumab: a case series
10.1080/09546634.2021.1899111 · 2022 · External reference
Severe generalized pustular psoriasis successfully treated with ixekizumab: a case report
10.1159/000526037 · 2022 · External reference
The update of treatment strategies in pediatrics with generalized pustular psoriasis in China
10.1002/ped4.12395 · ExternalCitation · doi-reference
Clinical disease measures in generalized pustular psoriasis
10.1007/s40257-021-00653-0 · ExternalCitation · doi-reference
Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, placebo-controlled phase 3 trial
10.1016/j.jaad.2024.09.031 · ExternalCitation · doi-reference
IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis
10.1016/j.jaci.2016.08.056 · ExternalCitation · doi-reference
Psoriasis pathogenesis and the development of novel targeted immune therapies
10.1016/j.jaci.2017.07.004 · ExternalCitation · doi-reference
IL-36 and IL-17A cooperatively induce a psoriasis-like gene expression response in human keratinocytes
10.1016/j.jid.2021.01.019 · ExternalCitation · doi-reference
Successful treatment of paediatric generalized pustular psoriasis with secukinumab: a case series
10.1080/09546634.2021.1899111 · ExternalCitation · doi-reference
Efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis across different regions of China: a post-hoc exploratory analysis of a phase III randomized controlled trial
10.1080/09546634.2025.2560505 · ExternalCitation · doi-reference
An update on generalized pustular psoriasis
10.1080/1744666x.2019.1648209 · ExternalCitation · doi-reference
Severe generalized pustular psoriasis successfully treated with ixekizumab: a case report
10.1159/000526037 · ExternalCitation · doi-reference
Vunakizumab and acitretin for elderly refractory generalized pustular psoriasis: a case report and comprehensive literature review
10.2147/btt.s592069 · ExternalCitation · doi-reference
The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab
10.3389/fimmu.2023.1292941 · ExternalCitation · doi-reference
